 Christina Coughlan
Concepts (338)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Alzheimer Disease | 9 | 2025 | 560 | 2.160 |
Why?
| | Extracellular Vesicles | 7 | 2025 | 146 | 1.780 |
Why?
| | Exosomes | 3 | 2023 | 103 | 0.840 |
Why?
| | Astrocytes | 4 | 2022 | 210 | 0.820 |
Why?
| | White Matter | 2 | 2023 | 145 | 0.780 |
Why?
| | Gliosis | 2 | 2023 | 28 | 0.750 |
Why?
| | Proteasome Endopeptidase Complex | 2 | 2022 | 156 | 0.750 |
Why?
| | Sialyltransferases | 8 | 1999 | 13 | 0.730 |
Why?
| | Amyloid beta-Protein Precursor | 5 | 2022 | 66 | 0.690 |
Why?
| | Healthy Aging | 1 | 2021 | 35 | 0.680 |
Why?
| | Glial Fibrillary Acidic Protein | 1 | 2021 | 100 | 0.680 |
Why?
| | Ultracentrifugation | 1 | 2020 | 52 | 0.670 |
Why?
| | Memory, Episodic | 1 | 2021 | 52 | 0.670 |
Why?
| | Saccharomyces cerevisiae | 5 | 2022 | 557 | 0.560 |
Why?
| | Amyloid beta-Peptides | 5 | 2022 | 220 | 0.510 |
Why?
| | Proteomics | 3 | 2024 | 1111 | 0.480 |
Why?
| | Peptide Fragments | 3 | 2022 | 706 | 0.480 |
Why?
| | Cognitive Dysfunction | 3 | 2025 | 383 | 0.450 |
Why?
| | Nanoparticles | 1 | 2020 | 482 | 0.450 |
Why?
| | Dexamethasone | 7 | 1999 | 370 | 0.410 |
Why?
| | Brain Ischemia | 2 | 2025 | 338 | 0.340 |
Why?
| | Neurons | 6 | 2022 | 1590 | 0.330 |
Why?
| | Herpes Zoster | 3 | 2024 | 316 | 0.330 |
Why?
| | Islet Amyloid Polypeptide | 2 | 2021 | 47 | 0.330 |
Why?
| | Down Syndrome | 4 | 2022 | 497 | 0.330 |
Why?
| | Sialoglycoproteins | 3 | 1997 | 159 | 0.290 |
Why?
| | Protein Folding | 3 | 2005 | 280 | 0.280 |
Why?
| | Neuroblastoma | 3 | 1999 | 160 | 0.250 |
Why?
| | Herpesvirus 3, Human | 3 | 2024 | 332 | 0.250 |
Why?
| | Stroke | 3 | 2023 | 1120 | 0.240 |
Why?
| | Proteome | 2 | 2024 | 472 | 0.240 |
Why?
| | Plasma | 2 | 2024 | 212 | 0.240 |
Why?
| | Sodium Bicarbonate | 1 | 2025 | 45 | 0.230 |
Why?
| | Tetraspanin 28 | 1 | 2024 | 6 | 0.230 |
Why?
| | Chordoma | 1 | 2024 | 14 | 0.230 |
Why?
| | Protein Conformation | 2 | 2005 | 934 | 0.230 |
Why?
| | DNA Transposable Elements | 1 | 2025 | 121 | 0.220 |
Why?
| | Idiopathic Pulmonary Fibrosis | 2 | 2024 | 657 | 0.220 |
Why?
| | alpha-Synuclein | 1 | 2024 | 35 | 0.220 |
Why?
| | Mitochondria | 2 | 2025 | 948 | 0.220 |
Why?
| | Acidosis | 1 | 2025 | 101 | 0.220 |
Why?
| | Amyloidogenic Proteins | 1 | 2024 | 16 | 0.220 |
Why?
| | Aprotinin | 1 | 2004 | 9 | 0.220 |
Why?
| | Varicella Zoster Virus Infection | 2 | 2024 | 24 | 0.220 |
Why?
| | Vacuoles | 1 | 2004 | 40 | 0.210 |
Why?
| | Osteoblasts | 1 | 2024 | 126 | 0.210 |
Why?
| | Interleukin-6 | 2 | 2025 | 778 | 0.210 |
Why?
| | Recombinant Proteins | 2 | 2007 | 1356 | 0.210 |
Why?
| | Glucocorticoids | 3 | 1999 | 596 | 0.210 |
Why?
| | Tumor Microenvironment | 2 | 2024 | 676 | 0.210 |
Why?
| | Neurodegenerative Diseases | 1 | 2005 | 135 | 0.200 |
Why?
| | Humans | 35 | 2025 | 137782 | 0.200 |
Why?
| | Cerebrovascular Circulation | 1 | 2025 | 250 | 0.200 |
Why?
| | Bleomycin | 1 | 2024 | 248 | 0.200 |
Why?
| | Epithelial-Mesenchymal Transition | 1 | 2024 | 209 | 0.200 |
Why?
| | Aged, 80 and over | 7 | 2025 | 7637 | 0.190 |
Why?
| | Colon | 1 | 2025 | 282 | 0.190 |
Why?
| | Diabetic Neuropathies | 1 | 2023 | 94 | 0.190 |
Why?
| | Cognition | 3 | 2025 | 1157 | 0.190 |
Why?
| | Ischemic Attack, Transient | 1 | 2023 | 65 | 0.190 |
Why?
| | Apolipoprotein E4 | 1 | 2022 | 37 | 0.190 |
Why?
| | Protein Processing, Post-Translational | 4 | 2011 | 465 | 0.190 |
Why?
| | Disease | 1 | 2003 | 98 | 0.190 |
Why?
| | Fatty Acids | 1 | 2025 | 443 | 0.180 |
Why?
| | Animals | 22 | 2025 | 36951 | 0.180 |
Why?
| | Bronchoalveolar Lavage Fluid | 1 | 2024 | 652 | 0.180 |
Why?
| | Retinal Drusen | 1 | 2021 | 31 | 0.180 |
Why?
| | Endoplasmic Reticulum | 1 | 2004 | 265 | 0.180 |
Why?
| | Virion | 1 | 2022 | 93 | 0.180 |
Why?
| | Peptides | 2 | 2024 | 985 | 0.180 |
Why?
| | Retinal Pigment Epithelium | 1 | 2021 | 77 | 0.180 |
Why?
| | Aldosterone | 4 | 1999 | 45 | 0.180 |
Why?
| | Arteritis | 1 | 2021 | 28 | 0.170 |
Why?
| | Biomarkers | 6 | 2025 | 4154 | 0.170 |
Why?
| | Central Nervous System Viral Diseases | 1 | 2022 | 79 | 0.170 |
Why?
| | Brain-Derived Neurotrophic Factor | 1 | 2021 | 131 | 0.170 |
Why?
| | Chemical Precipitation | 1 | 2020 | 37 | 0.170 |
Why?
| | Cell Polarity | 1 | 2021 | 141 | 0.170 |
Why?
| | Adipose Tissue | 1 | 2025 | 635 | 0.170 |
Why?
| | Stem Cells | 1 | 2025 | 594 | 0.170 |
Why?
| | Myelitis | 1 | 2022 | 107 | 0.170 |
Why?
| | Epigenesis, Genetic | 1 | 2025 | 660 | 0.170 |
Why?
| | Amyloid | 1 | 2021 | 87 | 0.170 |
Why?
| | Enterovirus D, Human | 1 | 2022 | 88 | 0.170 |
Why?
| | Cell Movement | 1 | 2024 | 967 | 0.160 |
Why?
| | Neuromuscular Diseases | 1 | 2022 | 132 | 0.160 |
Why?
| | Receptors, Chemokine | 1 | 2000 | 47 | 0.160 |
Why?
| | Macular Degeneration | 1 | 2021 | 164 | 0.160 |
Why?
| | Aged | 11 | 2025 | 24001 | 0.160 |
Why?
| | Chemokine CCL2 | 1 | 2000 | 115 | 0.160 |
Why?
| | Fibroblasts | 1 | 2024 | 996 | 0.150 |
Why?
| | Enterovirus Infections | 1 | 2022 | 177 | 0.150 |
Why?
| | Wnt-5a Protein | 1 | 2018 | 23 | 0.150 |
Why?
| | Renal Insufficiency, Chronic | 1 | 2025 | 617 | 0.150 |
Why?
| | Adrenal Cortex Hormones | 3 | 1999 | 565 | 0.150 |
Why?
| | Signal Transduction | 4 | 2021 | 5081 | 0.150 |
Why?
| | Frontotemporal Lobar Degeneration | 1 | 2017 | 18 | 0.140 |
Why?
| | Cell Communication | 2 | 2000 | 315 | 0.140 |
Why?
| | Kidney | 2 | 2015 | 1475 | 0.140 |
Why?
| | N-Acetylneuraminic Acid | 2 | 1999 | 12 | 0.140 |
Why?
| | Proteostasis Deficiencies | 1 | 2017 | 5 | 0.140 |
Why?
| | Aneuploidy | 1 | 2017 | 90 | 0.140 |
Why?
| | Melanoma | 1 | 2024 | 760 | 0.140 |
Why?
| | tau Proteins | 1 | 2017 | 90 | 0.130 |
Why?
| | Tumor Cells, Cultured | 5 | 2000 | 955 | 0.130 |
Why?
| | Trisomy | 1 | 2017 | 80 | 0.130 |
Why?
| | Brain Chemistry | 1 | 1996 | 117 | 0.120 |
Why?
| | Carcinoma, Hepatocellular | 2 | 1997 | 362 | 0.120 |
Why?
| | Proteins | 1 | 2021 | 1009 | 0.120 |
Why?
| | Isoenzymes | 1 | 1996 | 304 | 0.120 |
Why?
| | Models, Biological | 1 | 2003 | 1783 | 0.120 |
Why?
| | Aging | 2 | 2025 | 1865 | 0.120 |
Why?
| | Cystic Fibrosis | 1 | 2005 | 1114 | 0.120 |
Why?
| | Male | 13 | 2025 | 67906 | 0.110 |
Why?
| | Brain | 4 | 2023 | 2677 | 0.110 |
Why?
| | Molecular Sequence Data | 5 | 2015 | 2900 | 0.110 |
Why?
| | Middle Aged | 8 | 2025 | 33554 | 0.100 |
Why?
| | Oxidative Stress | 2 | 2021 | 1317 | 0.100 |
Why?
| | Mitochondrial Proteins | 1 | 2015 | 257 | 0.100 |
Why?
| | Female | 12 | 2025 | 73465 | 0.100 |
Why?
| | Membrane Proteins | 3 | 2024 | 1164 | 0.100 |
Why?
| | Enzyme Induction | 3 | 1997 | 90 | 0.100 |
Why?
| | Nerve Tissue Proteins | 1 | 1996 | 596 | 0.090 |
Why?
| | Obesity | 1 | 2025 | 2993 | 0.090 |
Why?
| | Amino Acid Sequence | 3 | 2015 | 2139 | 0.090 |
Why?
| | Transcription Factor AP-2 | 1 | 2011 | 82 | 0.090 |
Why?
| | Parkinson Disease | 1 | 2017 | 498 | 0.090 |
Why?
| | Glioma | 1 | 1995 | 395 | 0.090 |
Why?
| | Mice | 9 | 2025 | 17794 | 0.090 |
Why?
| | Ethanol | 1 | 2015 | 608 | 0.080 |
Why?
| | Palliative Care | 1 | 2017 | 758 | 0.080 |
Why?
| | Rats | 7 | 1999 | 5648 | 0.080 |
Why?
| | Mice, Inbred C57BL | 4 | 2025 | 5764 | 0.080 |
Why?
| | Membrane Transport Proteins | 1 | 2011 | 162 | 0.080 |
Why?
| | Adrenalectomy | 4 | 1999 | 68 | 0.080 |
Why?
| | Apoptosis | 2 | 2017 | 2553 | 0.080 |
Why?
| | Cells, Cultured | 4 | 2021 | 4193 | 0.080 |
Why?
| | Cell Line, Tumor | 3 | 2024 | 3415 | 0.080 |
Why?
| | Caregivers | 1 | 2017 | 888 | 0.080 |
Why?
| | Disease Models, Animal | 3 | 2025 | 4295 | 0.080 |
Why?
| | Attitude of Health Personnel | 1 | 2017 | 1172 | 0.080 |
Why?
| | Receptors, Nicotinic | 1 | 2011 | 334 | 0.080 |
Why?
| | Diabetes Mellitus, Type 2 | 1 | 2023 | 2534 | 0.080 |
Why?
| | Alcoholism | 1 | 2015 | 809 | 0.070 |
Why?
| | Glycosylation | 3 | 1999 | 151 | 0.070 |
Why?
| | Schizophrenia | 1 | 2011 | 439 | 0.070 |
Why?
| | Saccharomyces cerevisiae Proteins | 1 | 2011 | 405 | 0.070 |
Why?
| | Liver | 1 | 1996 | 1943 | 0.070 |
Why?
| | Drug Stability | 1 | 2007 | 167 | 0.070 |
Why?
| | DNA Primers | 1 | 2007 | 515 | 0.060 |
Why?
| | Adult | 4 | 2024 | 38023 | 0.060 |
Why?
| | Golgi Apparatus | 2 | 2004 | 100 | 0.060 |
Why?
| | Polysaccharides | 2 | 2004 | 79 | 0.060 |
Why?
| | Mutation | 4 | 2017 | 3959 | 0.060 |
Why?
| | Ultrasonography, Doppler, Transcranial | 1 | 2025 | 45 | 0.060 |
Why?
| | Middle Cerebral Artery | 1 | 2025 | 53 | 0.060 |
Why?
| | Intercellular Signaling Peptides and Proteins | 2 | 2024 | 382 | 0.060 |
Why?
| | Cytokines | 2 | 2024 | 2085 | 0.060 |
Why?
| | Endosomal Sorting Complexes Required for Transport | 1 | 2025 | 38 | 0.060 |
Why?
| | DNA Methylation | 2 | 2025 | 643 | 0.060 |
Why?
| | Case-Control Studies | 2 | 2023 | 3569 | 0.060 |
Why?
| | Calnexin | 1 | 2004 | 3 | 0.050 |
Why?
| | Centrifugation, Density Gradient | 1 | 2004 | 41 | 0.050 |
Why?
| | Cycloheximide | 1 | 2004 | 55 | 0.050 |
Why?
| | Concanavalin A | 1 | 2004 | 76 | 0.050 |
Why?
| | Fluorescent Antibody Technique, Indirect | 1 | 2004 | 51 | 0.050 |
Why?
| | Kinetics | 2 | 1998 | 1670 | 0.050 |
Why?
| | Precipitin Tests | 1 | 2004 | 100 | 0.050 |
Why?
| | Mass Spectrometry | 1 | 2007 | 739 | 0.050 |
Why?
| | Virus Activation | 1 | 2024 | 88 | 0.050 |
Why?
| | Multienzyme Complexes | 1 | 2004 | 68 | 0.050 |
Why?
| | Hippocampus | 2 | 2022 | 895 | 0.050 |
Why?
| | Cysteine Endopeptidases | 1 | 2004 | 73 | 0.050 |
Why?
| | Protein Synthesis Inhibitors | 1 | 2004 | 47 | 0.050 |
Why?
| | Time Factors | 2 | 2025 | 6834 | 0.050 |
Why?
| | Base Sequence | 1 | 2007 | 2181 | 0.050 |
Why?
| | Intermediate Filaments | 1 | 2023 | 28 | 0.050 |
Why?
| | Diet, High-Fat | 1 | 2025 | 247 | 0.050 |
Why?
| | Disulfides | 1 | 2004 | 107 | 0.050 |
Why?
| | Sensory Receptor Cells | 1 | 2024 | 98 | 0.050 |
Why?
| | Fungal Proteins | 1 | 2004 | 123 | 0.050 |
Why?
| | Sucrose | 1 | 2004 | 110 | 0.050 |
Why?
| | Neurites | 1 | 2023 | 48 | 0.050 |
Why?
| | Chemokines, CXC | 1 | 2003 | 70 | 0.050 |
Why?
| | Carbohydrate Sequence | 3 | 1999 | 27 | 0.050 |
Why?
| | Neurofilament Proteins | 1 | 2023 | 52 | 0.050 |
Why?
| | Diffusion Tensor Imaging | 1 | 2023 | 79 | 0.050 |
Why?
| | beta Catenin | 1 | 2025 | 253 | 0.050 |
Why?
| | Plasmids | 1 | 2004 | 363 | 0.050 |
Why?
| | Imipramine | 1 | 2022 | 12 | 0.050 |
Why?
| | Wnt Signaling Pathway | 1 | 2024 | 192 | 0.050 |
Why?
| | Growth Disorders | 1 | 2022 | 86 | 0.050 |
Why?
| | Retinal Ganglion Cells | 1 | 2003 | 110 | 0.050 |
Why?
| | Hearing Loss, Sensorineural | 1 | 2022 | 67 | 0.050 |
Why?
| | Chemokines | 1 | 2003 | 228 | 0.050 |
Why?
| | Densitometry | 1 | 2022 | 38 | 0.050 |
Why?
| | Gene Expression Regulation | 1 | 2011 | 2607 | 0.050 |
Why?
| | Virus Internalization | 1 | 2022 | 49 | 0.050 |
Why?
| | Diffusion Magnetic Resonance Imaging | 1 | 2023 | 154 | 0.050 |
Why?
| | Transforming Growth Factor beta | 1 | 2024 | 483 | 0.050 |
Why?
| | Viral Proteins | 1 | 2024 | 342 | 0.050 |
Why?
| | Polymerization | 1 | 2022 | 124 | 0.050 |
Why?
| | Catalysis | 1 | 2022 | 307 | 0.040 |
Why?
| | Protein Structure, Tertiary | 1 | 2004 | 861 | 0.040 |
Why?
| | Granulocyte-Macrophage Colony-Stimulating Factor | 1 | 2022 | 152 | 0.040 |
Why?
| | Oxidation-Reduction | 1 | 2025 | 1060 | 0.040 |
Why?
| | Cattle | 1 | 2004 | 985 | 0.040 |
Why?
| | Neuroimaging | 1 | 2023 | 260 | 0.040 |
Why?
| | Tissue Plasminogen Activator | 1 | 2023 | 225 | 0.040 |
Why?
| | Lectins | 2 | 1998 | 49 | 0.040 |
Why?
| | Interneurons | 1 | 2022 | 122 | 0.040 |
Why?
| | Receptors, HIV | 1 | 2000 | 24 | 0.040 |
Why?
| | Retina | 1 | 2003 | 298 | 0.040 |
Why?
| | DNA, Complementary | 1 | 2021 | 272 | 0.040 |
Why?
| | Immune System | 1 | 2022 | 177 | 0.040 |
Why?
| | Organoids | 1 | 2021 | 112 | 0.040 |
Why?
| | Double-Blind Method | 1 | 2025 | 1997 | 0.040 |
Why?
| | Sensitivity and Specificity | 1 | 2025 | 1946 | 0.040 |
Why?
| | Insulin-Like Growth Factor I | 1 | 2022 | 319 | 0.040 |
Why?
| | Teratocarcinoma | 1 | 2000 | 2 | 0.040 |
Why?
| | Pilot Projects | 1 | 2025 | 1713 | 0.040 |
Why?
| | Receptors, Dopamine D2 | 1 | 2000 | 97 | 0.040 |
Why?
| | Intracellular Space | 1 | 2020 | 68 | 0.040 |
Why?
| | Extracellular Space | 1 | 2020 | 119 | 0.040 |
Why?
| | Acyclovir | 1 | 2020 | 101 | 0.040 |
Why?
| | Phagocytosis | 1 | 2021 | 382 | 0.040 |
Why?
| | Cerebral Palsy | 1 | 2021 | 110 | 0.040 |
Why?
| | Phytohemagglutinins | 1 | 1999 | 30 | 0.040 |
Why?
| | Viral Envelope Proteins | 1 | 2020 | 84 | 0.040 |
Why?
| | Thrombosis | 1 | 2023 | 371 | 0.040 |
Why?
| | Cell Line | 2 | 2022 | 2847 | 0.040 |
Why?
| | DNA, Viral | 1 | 2021 | 364 | 0.040 |
Why?
| | Nicotine | 1 | 2021 | 334 | 0.040 |
Why?
| | Reactive Oxygen Species | 1 | 2021 | 623 | 0.040 |
Why?
| | Induced Pluripotent Stem Cells | 1 | 2021 | 248 | 0.040 |
Why?
| | Genotype | 1 | 2004 | 1917 | 0.040 |
Why?
| | Receptors, G-Protein-Coupled | 1 | 2000 | 220 | 0.040 |
Why?
| | Gene Expression Regulation, Neoplastic | 1 | 2024 | 1396 | 0.040 |
Why?
| | RNA, Messenger | 2 | 2011 | 2834 | 0.040 |
Why?
| | Fetuins | 1 | 1997 | 2 | 0.030 |
Why?
| | Asialoglycoproteins | 1 | 1997 | 2 | 0.030 |
Why?
| | Cytidine Monophosphate N-Acetylneuraminic Acid | 1 | 1997 | 3 | 0.030 |
Why?
| | Nervous System | 1 | 1998 | 67 | 0.030 |
Why?
| | Calcium Signaling | 1 | 2000 | 249 | 0.030 |
Why?
| | MicroRNAs | 1 | 2024 | 692 | 0.030 |
Why?
| | Protein Binding | 1 | 2004 | 2224 | 0.030 |
Why?
| | DNA-Binding Proteins | 1 | 2025 | 1502 | 0.030 |
Why?
| | alpha-Fetoproteins | 1 | 1997 | 46 | 0.030 |
Why?
| | Homozygote | 1 | 2017 | 203 | 0.030 |
Why?
| | Gene Dosage | 1 | 2017 | 140 | 0.030 |
Why?
| | Tretinoin | 1 | 1998 | 123 | 0.030 |
Why?
| | Chromosomes, Human, Pair 21 | 1 | 2017 | 44 | 0.030 |
Why?
| | Heterozygote | 1 | 2017 | 293 | 0.030 |
Why?
| | Transcription Factors | 1 | 2025 | 1719 | 0.030 |
Why?
| | Carbohydrate Conformation | 1 | 1996 | 11 | 0.030 |
Why?
| | Glycoproteins | 1 | 1998 | 342 | 0.030 |
Why?
| | Oligosaccharides | 1 | 1996 | 60 | 0.030 |
Why?
| | Glutathione Reductase | 1 | 2015 | 25 | 0.030 |
Why?
| | Parietal Lobe | 1 | 1996 | 58 | 0.030 |
Why?
| | Peroxiredoxins | 1 | 2015 | 24 | 0.030 |
Why?
| | Substrate Specificity | 1 | 1996 | 372 | 0.030 |
Why?
| | Brain Stem | 1 | 1996 | 94 | 0.030 |
Why?
| | Glutathione Transferase | 1 | 2015 | 106 | 0.030 |
Why?
| | Fetus | 1 | 2000 | 806 | 0.030 |
Why?
| | Nervous System Diseases | 1 | 1998 | 266 | 0.030 |
Why?
| | Acetylation | 1 | 2015 | 248 | 0.030 |
Why?
| | Aldehydes | 1 | 2015 | 145 | 0.030 |
Why?
| | Oxidative Phosphorylation | 1 | 2015 | 193 | 0.030 |
Why?
| | Focus Groups | 1 | 2017 | 530 | 0.030 |
Why?
| | Academic Medical Centers | 1 | 2017 | 512 | 0.030 |
Why?
| | Antiviral Agents | 1 | 2020 | 744 | 0.030 |
Why?
| | Cerebellum | 1 | 1996 | 224 | 0.030 |
Why?
| | Interviews as Topic | 1 | 2017 | 797 | 0.030 |
Why?
| | Glutathione | 1 | 2015 | 356 | 0.030 |
Why?
| | Risk Assessment | 1 | 2023 | 3461 | 0.030 |
Why?
| | Cell Differentiation | 2 | 1998 | 1991 | 0.030 |
Why?
| | Superoxide Dismutase | 1 | 2015 | 346 | 0.030 |
Why?
| | Mice, Transgenic | 1 | 2017 | 2167 | 0.020 |
Why?
| | Neoplasm Proteins | 1 | 1995 | 434 | 0.020 |
Why?
| | Lipid Metabolism | 1 | 2015 | 518 | 0.020 |
Why?
| | SEC Translocation Channels | 1 | 2011 | 10 | 0.020 |
Why?
| | Amino Acids | 1 | 2015 | 497 | 0.020 |
Why?
| | Lung | 1 | 2024 | 4060 | 0.020 |
Why?
| | alpha7 Nicotinic Acetylcholine Receptor | 1 | 2011 | 97 | 0.020 |
Why?
| | Inflammation | 1 | 2022 | 2838 | 0.020 |
Why?
| | Mutagenesis, Site-Directed | 1 | 2011 | 375 | 0.020 |
Why?
| | Protein Stability | 1 | 2011 | 176 | 0.020 |
Why?
| | Hydrophobic and Hydrophilic Interactions | 1 | 2011 | 187 | 0.020 |
Why?
| | Genetic Vectors | 1 | 2011 | 319 | 0.020 |
Why?
| | Cross-Sectional Studies | 1 | 2021 | 5478 | 0.020 |
Why?
| | Qualitative Research | 1 | 2017 | 1399 | 0.020 |
Why?
| | HeLa Cells | 1 | 2011 | 636 | 0.020 |
Why?
| | Protein Transport | 1 | 2011 | 445 | 0.020 |
Why?
| | RNA, Small Interfering | 1 | 2011 | 622 | 0.020 |
Why?
| | Treatment Outcome | 1 | 2023 | 10837 | 0.020 |
Why?
| | Promoter Regions, Genetic | 1 | 2011 | 1251 | 0.020 |
Why?
| | Antineoplastic Agents | 1 | 1998 | 2129 | 0.020 |
Why?
| | Transcription, Genetic | 1 | 2011 | 1457 | 0.010 |
Why?
| | Retrospective Studies | 1 | 2022 | 15682 | 0.010 |
Why?
| | Adolescent | 1 | 2023 | 21574 | 0.010 |
Why?
| | In Situ Nick-End Labeling | 1 | 2003 | 124 | 0.010 |
Why?
| | Chick Embryo | 1 | 2003 | 130 | 0.010 |
Why?
| | Glycogen Synthase Kinase 3 beta | 1 | 2003 | 72 | 0.010 |
Why?
| | Chemokine CXCL12 | 1 | 2003 | 81 | 0.010 |
Why?
| | Infant | 1 | 2017 | 9482 | 0.010 |
Why?
| | Glycogen Synthase Kinase 3 | 1 | 2003 | 82 | 0.010 |
Why?
| | Receptors, CXCR4 | 1 | 2003 | 86 | 0.010 |
Why?
| | Nerve Growth Factors | 1 | 2003 | 79 | 0.010 |
Why?
| | Cell Count | 1 | 2003 | 324 | 0.010 |
Why?
| | Cyclic AMP-Dependent Protein Kinases | 1 | 2003 | 136 | 0.010 |
Why?
| | Cyclic AMP | 1 | 2003 | 234 | 0.010 |
Why?
| | Mitogen-Activated Protein Kinases | 1 | 2003 | 313 | 0.010 |
Why?
| | Apelin Receptors | 1 | 2000 | 4 | 0.010 |
Why?
| | Dopamine D2 Receptor Antagonists | 1 | 2000 | 5 | 0.010 |
Why?
| | Apelin | 1 | 2000 | 10 | 0.010 |
Why?
| | Adipokines | 1 | 2000 | 49 | 0.010 |
Why?
| | Receptors, Virus | 1 | 2000 | 83 | 0.010 |
Why?
| | Simian Immunodeficiency Virus | 1 | 2000 | 88 | 0.010 |
Why?
| | Cell Survival | 1 | 2003 | 1120 | 0.010 |
Why?
| | Primates | 1 | 2000 | 126 | 0.010 |
Why?
| | Swainsonine | 1 | 1999 | 1 | 0.010 |
Why?
| | 1-Deoxynojirimycin | 1 | 1999 | 1 | 0.010 |
Why?
| | Mannosidases | 1 | 1999 | 4 | 0.010 |
Why?
| | Neuraminidase | 1 | 1999 | 24 | 0.010 |
Why?
| | Tissue Distribution | 1 | 1999 | 332 | 0.010 |
Why?
| | Phosphorylation | 1 | 2003 | 1759 | 0.010 |
Why?
| | Transfection | 1 | 2000 | 945 | 0.010 |
Why?
| | Biological Transport | 1 | 1999 | 418 | 0.010 |
Why?
| | Leukocytes, Mononuclear | 1 | 2000 | 558 | 0.010 |
Why?
| | Mice, Inbred BALB C | 1 | 2000 | 1272 | 0.010 |
Why?
| | Solubility | 1 | 1998 | 245 | 0.010 |
Why?
| | Pituitary Neoplasms | 1 | 1999 | 190 | 0.010 |
Why?
| | Blotting, Western | 1 | 1999 | 1227 | 0.010 |
Why?
| | Carrier Proteins | 1 | 2000 | 771 | 0.010 |
Why?
| | Mice, Knockout | 1 | 2003 | 3018 | 0.010 |
Why?
| | HIV-1 | 1 | 2000 | 864 | 0.010 |
Why?
| | Antibodies, Monoclonal | 1 | 2000 | 1430 | 0.010 |
Why?
| | T-Lymphocytes | 1 | 2000 | 1998 | 0.010 |
Why?
|
|
Coughlan's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors People whose addresses are nearby this person. _
|